CDKN2A and meningioma: We saw significant up-regulation of similar cell cycle pathways in meningiomas with CDKN2A deletions as we observed in CDKN2Ahigh tumors except these pathways generally centered around the G2M checkpoint/transition instead of the G1-S checkpoint (Fig. 3g, i).